12:00 AM
Aug 19, 2013
 |  BC Week In Review  |  Company News  |  Other News

Gilead, Lupin cardiovascular news

Gilead granted Lupin rights to launch a generic version of Gilead's angina drug Ranexa ranolazine on Feb. 27, 2019. The deal is part of...

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >